Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Kestra Medical Technologies, Ltd. before investing.

In this article, we go over a few key elements for understanding Kestra Medical Technologies, Ltd.’s stock price such as:

• Kestra Medical Technologies, Ltd.’s current stock price and volume
• Why Kestra Medical Technologies, Ltd.’s stock price changed recently
• Upgrades and downgrades for KMTS from analysts
• KMTS’s stock price momentum as measured by its relative strength

About Kestra Medical Technologies, Ltd. (KMTS)

Before we jump into Kestra Medical Technologies, Ltd.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Want to learn more about Kestra Medical Technologies, Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Kestra Medical Technologies, Ltd..

Kestra Medical Technologies, Ltd.’s Stock Price as of Market Close

As of December 02, 2025, 11:28 AM, CST, Kestra Medical Technologies, Ltd.’s stock price was $23.490.

Kestra Medical Technologies, Ltd. is down 4.86% from its previous closing price of $24.690.

During the last market session, Kestra Medical Technologies, Ltd.’s stock traded between $23.350 and $26.230. Currently, there are approximately 51.30 million shares outstanding for Kestra Medical Technologies, Ltd..

Kestra Medical Technologies, Ltd.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Kestra Medical Technologies, Ltd. Stock Price History

Kestra Medical Technologies, Ltd.’s (KMTS) price is currently down 12.94% so far this month.

During the month of December, Kestra Medical Technologies, Ltd.’s stock price has reached a high of $26.230 and a low of $23.170.

Over the last year, Kestra Medical Technologies, Ltd. has hit prices as high as $30.000 and as low as $13.250.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Kestra Medical Technologies, Ltd. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 01, 2025, there were 4 analysts who downgraded Kestra Medical Technologies, Ltd.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Kestra Medical Technologies, Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Kestra Medical Technologies, Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Kestra Medical Technologies, Ltd.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Kestra Medical Technologies, Ltd. (KMTS) by visiting AAII Stock Evaluator.

Relative Price Strength of Kestra Medical Technologies, Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 01, 2025, Kestra Medical Technologies, Ltd. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Kestra Medical Technologies, Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Kestra Medical Technologies, Ltd. Stock Price: Bottom Line

As of December 2, 2025, Kestra Medical Technologies, Ltd.’s stock price is $23.490, which is down 4.86% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Kestra Medical Technologies, Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.